Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
Synairgen: shares soar of positive Covid-19 test results
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Gamma Communications
Stonking Small Caps: update sees shares fall back
This fast-growing provider of unified communications is a fantastic company, generating attractive operating margins and heaps…
Whopping dividends from AIM
Updates covered here include several AIM and small cap companies offering high dividend payouts. While some…
More on MJ Hudson Group PLC
DUKE of hazard | Bonkers Bargain ahead again
Updates from AIM covered here includes news of the suspension of trading in the shares of a…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Pittards
Coronavirus impact: 30 Sept - some big pandemic winners and losers
Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Synairgen
Not so wacky, but still unusual!
A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Venture Life
US approval | Successful sale | Angling success
News covered here includes our assessment of pleasing results from a specialist fishing tackle retailer, although…
Bonkers Bargain delights | Activist impact | Another AIM mover?
News covered in the update here includes our assessment of impressive results from one of our…
